---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-039023"
form_type: "8-K"
ticker: "COCP"
cik: "0001412486"
company_name: "Cocrystal Pharma, Inc."
filed_at: "2026-08-18T20:30:32+00:00"
generated_at: "2026-08-18T20:32:21.154979+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Cocrystal Pharma appoints Carol L. Brosgart to board of directors

## Summary
- Carol L. Brosgart appointed as director effective August 12, 2026.
- No arrangements or understandings with other persons regarding her selection.
- No family relationships or related party transactions requiring disclosure.

## SEC filing metadata
- accession: 0001493152-26-039023
- form_type: 8-K
- ticker: COCP
- cik: 0001412486
- company_name: Cocrystal Pharma, Inc.
- filed_at: 2026-08-18T20:30:32+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1412486/000149315226039023/0001493152-26-039023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1412486/000149315226039023/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-039023
- JSON: https://secwatch.observer/filing/0001493152-26-039023.json
- Plain text: https://secwatch.observer/filing/0001493152-26-039023.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.